Cargando…
Fibroproliferative changes on high-resolution CT in the acute respiratory distress syndrome predict mortality and ventilator dependency: a prospective observational cohort study
OBJECTIVES: To examine whether the extent of fibroproliferative changes on high-resolution CT (HRCT) scan influences prognosis, ventilator dependency and the associated outcomes in patients with early acute respiratory distress syndrome (ARDS). DESIGN: A prospective observational cohort study. SETTI...
Autores principales: | Ichikado, Kazuya, Muranaka, Hiroyuki, Gushima, Yasuhiro, Kotani, Toru, Nader, Habashi M, Fujimoto, Kiminori, Johkoh, Takeshi, Iwamoto, Norihiro, Kawamura, Kodai, Nagano, Junji, Fukuda, Koichiro, Hirata, Naomi, Yoshinaga, Takeshi, Ichiyasu, Hidenori, Tsumura, Shinsuke, Kohrogi, Hirotsugu, Kawaguchi, Atsushi, Yoshioka, Masakazu, Sakuma, Tsutomu, Suga, Moritaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293132/ https://www.ncbi.nlm.nih.gov/pubmed/22382117 http://dx.doi.org/10.1136/bmjopen-2011-000545 |
Ejemplares similares
-
Clinical characteristics and prognosis of drug-associated acute respiratory distress syndrome compared with non-drug-associated acute respiratory distress syndrome: a single-centre retrospective study in Japan
por: Anan, Keisuke, et al.
Publicado: (2017) -
Monocyte count and the risk for acute exacerbation of fibrosing interstitial lung disease: A retrospective cohort study
por: Kawamura, Kodai, et al.
Publicado: (2020) -
An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J)
por: Ichikado, Kazuya, et al.
Publicado: (2023) -
The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: a retrospective propensity matched cohort study
por: Takaki, Makoto, et al.
Publicado: (2017) -
Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience
por: Kawamura, Kodai, et al.
Publicado: (2019)